[68Ga]Ga-PSMA-11 has recently been approved by the US Food and Drug Administration as a radiopharmaceutical for PET imaging of prostate cancer. To meet higher demand for this tracer, procedures for its synthesis using both generator-eluted and cyclotron-produced 68Ga are described.
- Melissa E. Rodnick
- Carina Sollert
- Peter J. H. Scott